Intrinsic Value of S&P & Nasdaq Contact Us

Takeda Pharmaceutical Company Limited TKPHF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • JP • USD

SharesGrow Score
67/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — TKPHF

Takeda Pharmaceutical Company Limited (TKPHF) has a market capitalization of $54.53B and trades at $34.52. The 52-week range is 26.1-39.2.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 0.5, Earnings Per Share (EPS) of $68.36, annual revenue of $4.58T.

The stock has a beta of 0.13, a last dividend of $1.1715, operates in the Healthcare sector.

Trading Data
Current Price$34.52
52-Week Range26.1-39.2
Volume500
Avg Volume (30D)14.31K
Market Cap$54.53B
Beta (1Y)0.13
Last Dividend$1.1715
Company
IPO Date2008-06-25
Employees49,281
CEOChristophe Weber
CountryJP
ExchangeOther OTC
CurrencyUSD
ISINJP3463000004
Income (Latest Year)
Revenue$4.58T
Gross Profit$3T
EBITDA$1.07T
Operating Income$342.59B
Net Income$107.93B
EPS$68.36
EPS Diluted$67.23
Shares Outstanding$1.58B
Balance Sheet (Latest Year)
Total Assets$14.25T
Current Assets$2.52T
Cash & ST Investments$405.59B
Total Liabilities$7.31T
Total Debt$4.52T
Net Debt$4.13T
Total Equity$6.94T
Debt / Equity0.65
Valuation Ratios
P/E Ratio0.5
P/S Ratio0.01
P/B Ratio0.01
EV/EBITDA (approx)0.1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message